Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001650664-25-000102
Filing Date
2025-06-10
Accepted
2025-06-10 16:19:16
Documents
2
Period of Report
2025-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749586749.html 4  
1 FORM 4 wk-form4_1749586749.xml 4 3831
2 EX-24.1 a2025-03x05powerofattorney.htm EX-24.1 8740
  Complete submission text file 0001650664-25-000102.txt   13954
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Issuer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Scadden David (Reporting) CIK: 0001707715 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37687 | Film No.: 251037351